…quivocal.’Conclusion In conclusion, if we were to apply the BSE Amyloidosis Guideline across our multi-site tertiary centre, this would cla…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 185 of 2459…duction of 52% ±12 (95% CI) was found in those with statins and Inclisiran. For those intolerant of statins, use of Inclisiran led to a me…
…h concern and a leading risk factor for cardiovascular disease. Zilebesiran, an investigational RNA interference therapeutic, aims to reduc…
…regarding their applicability as diagnostic biomarkers in human AKI.Abstract BS09 Figure 1PRISMA flow diagramAbstract BS09 Figure 2…
…rd with adjunctive social network distribution arm will receive doxy-PEP directly from referring index participants. Both index and alte…
…014). Tonsillectomy was ineffective. IL-1 inhibitors (anakinra, canakinumab) were beneficial in refractory cases. Cluster analysis revealed…
…ctice are compared with bupivacaine alone. We hypothesized that bupivacaine alone increases the duration of motor block, sensory block, and…
…methods A literature search was conducted in PubMed, Embase and Cochrane databases to identify reference studies reporting infectious co…
…thogenic mediators, while neonatal Fc receptor antagonists (eg, efgartigimod) offer novel therapeutic potential. Both PLEX and efgartigimod …
…upregulation of cerebral metabolism in vulnerable brain tissue. Ketamine appears to inhibit SDs both in vitro and in patient series of s…
…ate mofetil (MMF) and other immunosuppressants in patients with systemic lupus erythematosus (SLE) on maintenance therapy using data from the Lupus Registry…
…±8.84 years. The most common initial clinical features included parkinsonism (61/117, 52.1%), cerebellar signs (46/85, 54.1%), cognitive imp…